Showing results (1681-1690 of 2,234) with videos related to
Sort By:
Pageof 224
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 13, 2008
Studies of finite molecular chains: synthesis, structural, magnetic and inelastic neutron scattering studies of hexa- and heptanuclear chromium horseshoesStefan T Ochsenbein, Floriana Tuna, Marzio Rancan, et al.Bioorganic & Medicinal Chemistry|March 26, 2017
Thiazolidine derivatives as potent and selective inhibitors of the PIM kinase familyCarole J R Bataille, Méabh B Brennan, Simon Byrne, et al.Translational Psychiatry|April 19, 2017
Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association dataJ Gibson, T C Russ, M J Adams, et al.Open Forum Infectious Diseases|March 12, 2025
Etiology and Antimicrobial Resistance of Culture-Positive Infections in Ugandan Infants: A Cohort Study of 7000 Neonates and InfantsHannah G Davies, Mary Kyohere, Valerie Tusubira, et al.Nature|August 19, 2005
Global hotspots of species richness are not congruent with endemism or threatC David L Orme, Richard G Davies, Malcolm Burgess, et al.Bioorganic & Medicinal Chemistry|October 27, 2005
Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase BIan Collins, John Caldwell, Tatiana Fonseca, et al.Gene Therapy|December 10, 2015
Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemiaM R Kibbe, A T Hirsch, F O Mendelsohn, et al.Intelligence|February 26, 2016
Examining non-syndromic autosomal recessive intellectual disability (NS-ARID) genes for an enriched association with intelligence differencesW D Hill, G Davies, D C Liewald, et al.Journal of Medicinal Chemistry|February 16, 2010
Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt)Tatiana McHardy, John J Caldwell, Kwai-Ming Cheung, et al.The Journal of Pharmacology and Experimental Therapeutics|April 27, 2017
Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3K<i>δ</i>Rodger A Allen, Daniel C Brookings, Mark J Powell, et al.Pageof 224